Keyphrases
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
100%
Immune Checkpoint
100%
HIV Antibodies
100%
Antibody Induction
100%
Antibody Response
66%
Immunoglobulin
66%
Broadly Neutralizing Antibodies
66%
HIV-1 Envelope
66%
OX40
66%
BNAbs
66%
Knock-in Mouse Model
33%
Mouse Model
33%
Human Immunodeficiency Virus Type 1 (HIV-1)
33%
Neutralizing Antibodies
33%
Macaque
33%
Vaccination
33%
Antibody Targeting
33%
Genetic Features
33%
Germinal Center
33%
Immune Cells
33%
Programmed Death-ligand 1 (PD-L1)
33%
Infected Individual
33%
Vaccine Development
33%
Rhesus Macaque
33%
Vaccine Strategy
33%
B-cell Precursors
33%
Naïve B Cells
33%
HIV Envelope
33%
HIV Vaccine
33%
OX40 Agonist
33%
Agonist Antibody
33%
CTLA-4 Blockade
33%
T Follicular Helper Cells
33%
Protective Titer
33%
Regulatory Control
33%
CD4-binding Site
33%
Germinal Center B
33%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Neutralizing Antibody
71%
CTLA-4
57%
Precursor
42%
Antibody Response
28%
Intravenous Immunoglobulin
28%
Germinal Center
28%
Mouse Model
14%
Immunocompetent Cell
14%
Blood Plasma
14%
Titer
14%
CD4
14%
Human Immunodeficiency Virus
14%
Binding Site
14%
Agonist
14%
Rhesus Monkey
14%
Macaca
14%
Regulatory Cell
14%
Naive B Cell
14%
Follicular B Helper T Cells
14%